Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which is Best?

To examine the optimal method of assessing response to neoadjuvant therapy (NAT) in operable pancreatic ductal adenocarcinoma (PDAC) patients. PDAC response to NAT is measured with biochemical, radiographic and pathologic parameters, which can often be discordant with each other. PDAC patients under...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of surgery 2024-12
Hauptverfasser:	Ahmad, M Usman, Javadi, Christopher S, Chang, Julia D, Forgó, Erna, Delitto, Daniel J, Dua, Monica M, Fisher, Jr, George A, Heestand, Gregory M, Chang, Daniel T, Pollom, Erqi, Vitzthum, Lucas K, Kirane, Amanda, Lee, Byrne, Visser, Brendan C, Norton, Jeffrey A, Poultsides, George A
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!